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Based on the systematic assessment of symptoms, Emil 
Kraepelin over 100 years ago defined catatonia and motor 
symptoms as a feature of schizophrenia [1]. In fact, about 
two-third of first-episode schizophrenia patients exhibit 
motor deficits; in multi-episode patients, the frequency is 
even higher. Irrespective of motor side-effects of antipsy-
chotic treatment, motor slowing has been detected during 
the early course of psychosis. In this issue, in antipsychotic-
naive individuals at high risk for psychosis (CHR), Damme 
et al. [2] used a computerized finger tapping task and clini-
cal interviews. They could demonstrate motor slowing in 
the CHR individuals compared to healthy controls and a 
relationship to negative, but not positive symptoms. Accord-
ingly, in medicated young schizophrenia patients without 
extrapyramidal symptoms, better fine motor function was 
correlated with less-severe negative symptoms [3].
Neurological soft signs (NSS) refer to minor deficits in 
motor coordination, sensory integration, and disinhibition, 
and are highly prevalent in patients with schizophrenia, but 
also in those with bipolar or obsessive–compulsive disorder. 
In a large sample of patients with psychosis, motor dysfunc-
tion at baseline has also been related to symptoms of obses-
sive–compulsive after a follow-up of 3 years [4], suggesting 
that motor symptoms may precede co-occurring obses-
sive–compulsive symptoms. Individuals with ultra-high risk 
for psychosis have been shown to exhibit a higher prevalence 
of NSS sensory integration items than individuals with schi-
zotypy and healthy controls, and these items could discrimi-
nate individuals at high risk from healthy controls with an 
accuracy of about 85% [5]. Therefore, NSS have been pro-
posed as biomarkers to detect and to discriminate individuals 
in different stages of psychosis from healthy controls. In a 
large sample of patients with schizophrenia, their unaffected 
first-degree relatives, individuals with schizotypal personal-
ity disorder, other psychiatric patients and healthy controls, 
and patients along the schizophrenia continuum showed 
increased levels of NSS compared to healthy controls and 
other psychiatric patients. The abnormal developmental 
trajectory of NSS in schizophrenia supports the endophe-
notype hypothesis and relates NSS to neurodevelopmental 
disturbances [6].
In remitted schizophrenia patients, Feng et al. [7] investi-
gated NSS and their association with cognitive deficits. They 
found that six subitems of NSS and neurocognitive deficits 
met criteria of endophenotype and hypothesized that covari-
ation of sensory integration and cognitive domains including 
information processing speed, attention, and social cogni-
tion suggest an overlap of compromised underlying neural 
systems. NSS have been reported to be associated with dis-
turbed cortical–subcortical–cerebellar circuitry in schizo-
phrenia. Using a graph theoretical approach and regional 
network analysis, it has been demonstrated that NSS were 
associated with betweenness centrality involving the infe-
rior orbital frontal cortex, the middle temporal cortex, the 
hippocampus, the supramarginal cortex, the amygdala, and 
the cerebellum. Global network analysis revealed NSS to be 
associated with the distribution of network hubs involving 
the superior medial frontal cortex, the temporal cortices, the 
postcentral cortex, the amygdala, and the cerebellum [8]. In 
individuals with ultra-high-risk for psychosis, NSS scores 
were associated with decreased gray matter volume in the 
superior and medial frontal cortex, the rectal cortex, the 
pre- and postcentral cortex, the insula, the caudate, and the 
cerebellum [9]. The cerebellum is well known to be involved 
in motor control, but functional magnetic resonance imag-
ing (fMRI) and positron emission tomography (PET) studies 
have also shown the involvement of the cerebellum in cogni-
tion. The cerebellum has been implicated in the pathophysi-
ology of schizophrenia with the cortico-thalamo-cerebellar 
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circuit receiving particular attention. However, the under-
lying mechanisms are unknown and are hypothesized to 
involve a glutamatergic deficit in cerebellar subregions of 
schizophrenia patients [10]. In future studies, multimodal 
neuroimaging should be applied to assess affected brain cir-
cuits and the pathophysiological basis of NSS during lifes-
pan in individuals with psychosis.
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